Lilly's SURPASS-1 Results Published in The Lancet Show Tirzepatide's Superior A1C and Body Weight Reductions Versus Placebo in Adults With Type 2 Diabetes
Blood markers to track: serum glutathione, plasma MDA, RBC glutathione peroxidase activity
Therefore, in order to contextualize the complexity of the metabolic network and the impact of Gclc on it, we analyzed our transcriptomic data using Compass, a flux balance analysis-based approach that allows the characterization and interpretation of metabolic diversity at the single cell level 70,71
"In some of the trials, we saw that individuals who had those variants were unable to lower their blood glucose levels as effectively after six months of treatment," said Anna Gloyn, DPhil, professor of pediatrics and of genetics, and one of the study's senior authors
Dosage: 250-300 mcg/day subcutaneous injection